首页> 美国卫生研究院文献>GMS German Medical Science >Photodynamic therapy (PDT) and waterfiltered infrared A (wIRA) in patients with recalcitrant common hand and foot warts
【2h】

Photodynamic therapy (PDT) and waterfiltered infrared A (wIRA) in patients with recalcitrant common hand and foot warts

机译:顽固性普通手足疣患者的光动力疗法(PDT)和水滤红外A(wIRA)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Common warts (verrucae vulgares) are human papilloma virus (HPV) infections with a high incidence and prevalence, most often affecting hands and feet, being able to impair quality of life. About 30 different therapeutic regimens described in literature reveal a lack of a single striking strategy. Recent publications showed positive results of photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) in the treatment of HPV-induced skin diseases, especially warts, using visible light (VIS) to stimulate an absorption band of endogenously formed protoporphyrin IX. Additional experiences adding waterfiltered infrared A (wIRA) during 5-ALA-PDT revealed positive effects. >Aim of the study: First prospective randomised controlled blind study including PDT and wIRA in the treatment of recalcitrant common hand and foot warts. Comparison of "5-ALA cream (ALA) vs. placebo cream (PLC)" and "irradiation with visible light and wIRA (VIS+wIRA) vs. irradiation with visible light alone (VIS)". >Methods: Pre-treatment with keratolysis (salicylic acid) and curettage. PDT treatment: topical application of 5-ALA (Medac) in "unguentum emulsificans aquosum" vs. placebo; irradiation: combination of VIS and a large amount of wIRA (Hydrosun® radiator type 501, 4 mm water cuvette, waterfiltered spectrum 590-1400 nm, contact-free, typically painless) vs. VIS alone. Post-treatment with retinoic acid ointment. One to three therapy cycles every 3 weeks. Main variable of interest: "Percent change of total wart area of each patient over the time" (18 weeks). Global judgement by patient and by physician and subjective rating of feeling/pain (visual analogue scales). 80 patients with therapy-resistant common hand and foot warts were assigned randomly into one of the four therapy groups with comparable numbers of warts at comparable sites in all groups. >Results: The individual total wart area decreased during 18 weeks in group 1 (ALA+VIS+wIRA) and in group 2 (PLC+VIS+wIRA) significantly more than in both groups without wIRA (group 3 (ALA+VIS) and 4 (PLC+VIS)): medians and interquartile ranges: -94% (-100%/-84%) vs. -99% (-100%/-71%) vs. -47% (-75%/0%) vs. -73% (-92%/-27%). After 18 weeks the two groups with wIRA differed remarkably from the two groups without wIRA: 42% vs. 7% completely cured patients; 72% vs. 34% vanished warts. Global judgement by patient and by physician and subjective rating of feeling was much better in the two groups with wIRA than in the two groups without wIRA. >Conclusions: The above described complete treatment scheme of hand and foot warts (keratolysis, curettage, PDT treatment, irradiation with VIS+wIRA, retinoic acid ointment; three therapy cycles every 3 weeks) proved to be effective. Within this treatment scheme wIRA as non-invasive and painless treatment modality revealed to be an important, effective factor, while photodynamic therapy with 5-ALA in the described form did not contribute recognisably - neither alone (without wIRA) nor in combination with wIRA - to a clinical improvement. For future treatment of warts an even improved scheme is proposed: one treatment cycle (keratolysis, curettage, wIRA, without PDT) once a week for six to nine weeks.
机译:>背景:常见的疣(寻常疣)是人乳头瘤病毒(HPV)感染,其发病率和患病率很高,最常影响手脚,能够损害生活质量。文献中描述的大约30种不同的治疗方案表明缺乏单一的打击策略。最近的出版物显示,使用可见光(VIS)刺激内源性原卟啉IX的吸收带,用5-氨基乙酰丙酸(5-ALA)进行光动力疗法(PDT)治疗HPV诱发的皮肤疾病,尤其是疣,取得了积极成果。在5-ALA-PDT期间添加水滤红外A(wIRA)的其他经验显示出积极的作用。 >研究目的:首项前瞻性随机对照盲研究,包括PDT和wIRA治疗难治性普通手足疣。比较“ 5-ALA乳膏(ALA)与安慰剂乳膏(PLC)”和“可见光和wIRA照射(VIS + wIRA)与单独可见光照射(VIS)”的比较。 >方法:用角质层溶解术(水杨酸)和刮宫术进行预处理。 PDT治疗:在安慰剂中局部使用5-ALA(Medac)与“安慰剂”;辐射:将VIS和大量wIRA(Hydrosun ®辐射器类型501、4毫米水杯,水过滤光谱590-1400 nm,无接触,通常无痛)的组合与单独使用VIS相比。用视黄酸软膏进行后处理。每3周进行一到三个治疗周期。感兴趣的主要变量:“每个患者在整个时间内总疣面积的百分比变化”(18周)。患者和医师的整体判断以及感觉/疼痛的主观评价(视觉模拟量表)。将80例具有治疗抵抗力的普通手足癣患者随机分为四个治疗组之一,所有组中可比部位的疣数均相同。 >结果:第1组(ALA + VIS + wIRA)和第2组(PLC + VIS + wIRA)在18周内个体总疣面积减少量均明显高于无wIRA的两组(第3组) (ALA + VIS)和4(PLC + VIS)):中位数和四分位数范围:-94%(-100%/-84%)与-99%(-100%/-71%)与-47% (-75%/ 0%)与-73%(-92%/-27%)。 18周后,两组有wIRA的患者与两组没有wIRA的患者有显着差异:42%vs. 7%完全治愈的患者; 72%和34%的疣消失了。有wIRA的两组患者和医生的整体判断以及感觉的主观评价要好于无wIRA的两组。 >结论:上述手足疣的完整治疗方案(角质溶解,刮宫术,PDT治疗,VIS + wIRA照射,视黄酸软膏;每3周3个治疗周期)被证明是有效的。在该治疗方案中,wIRA作为无创且无痛的治疗方式已被证明是重要的有效因素,而采用上述形式的5-ALA进行的光动力疗法并没有明显的作用-既不单独使用(不使用wIRA)也不与wIRA联合使用-改善临床。对于将来的疣治疗,提出了一种甚至更好的方案:每周治疗一次(角质溶解,刮宫,wiRA,不使用PDT),每周治疗6至9周。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号